Pretty sure there is more than one influenza vaccine, and that gets modified most years to cope with mutations so once they find a few approaches that work they, who ever they happen to be will on a perennial winner. AND there will always be people who it does not work for or do not vaccinate, so there will be plenty of room for a good ARDS solution (we hope/expect), and maybe whatever else needs remediating, just for COVID-19, then there are all the other ARDS causes.
It will be wonderful when we can move on to the other solutions Mesoblast has been working on, and those not yet started. Yes the pandemic is front and centre but one day it will not be.
Moderna, page-33
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |